国产精品99一区二区三_免费中文日韩_国产在线精品一区二区_日本成人手机在线

Drugs reprogram genes in breast tumors may prevent endocrine resistance: study

Source: Xinhua| 2019-04-23 06:32:06|Editor: yan
Video PlayerClose

CHICAGO, April 22 (Xinhua) -- Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene pathways, according to a study posted on the website of the University of Illinois (UI) on Monday.

Endocrine resistance is a condition when some patients will either not respond or will develop resistance to the drugs over time during endocrine therapy.

Based upon prior research, UI researchers hypothesized that two elements might work together to cause endocrine resistance: the hormone receptor ERa, which is responsive to estrogen and is expressed in 70 percent of all breast cancers; and the nuclear transport gene XPO1, which removes foreign materials from cells' nuclei.

Combining the drugs selinexor, which prevents XPO1 anti-cancer proteins from functioning, and 4-OHT, which inhibits estrogen receptors from responding to the hormone, might be more effective than either drug alone, the researchers hypothesized.

In the current study, the researchers treated endocrine-resistant tumor cells with 4-OHT or selinexor alone, or with a combination of both drugs to determine how each of these treatment protocols affected the tumors' survival and functioning.

When they tested the three treatments on human breast tumor cells implanted in mice, they found that the combination of 4-OHT and selinexor caused the tumors to regress faster and more completely than either drug alone, and the effects continued for several weeks after treatment ended.

In analyzing genetic activity in human endocrine-resistant breast tumors, they found that the drug combination increased the expression of more than 100 genes and decreased the expression of 132 other genes that were not affected by either drug alone.

The drug combination appeared to promote sustained tumor regression by decreasing the activity of genes that were associated with endocrine resistance and metastasis. Among these were sets of genes regulated by the protein Akt that control cells' survival, proliferation and migration.

The study involved human breast cancer cells that were implanted in mice and analyses of the genes expressed by endocrine-resistant breast tumors.

The study has been published in the journal Cancers.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011105521379994861
主站蜘蛛池模板: 达日县| 敦化市| 衡阳县| 都江堰市| 洪雅县| 黔江区| 清镇市| 朔州市| 邮箱| 彭泽县| 杨浦区| 伊宁县| 申扎县| 奉化市| 山丹县| 洞头县| 犍为县| 永丰县| 涞源县| 砀山县| 稷山县| 本溪市| 璧山县| 咸宁市| 花莲县| 宝丰县| 托克托县| 曲阜市| 九寨沟县| 池州市| 中卫市| 额敏县| 合江县| 阳春市| 墨脱县| 锡林浩特市| 普兰店市| 绥芬河市| 友谊县| 西乌珠穆沁旗| 大丰市|